Opatanol Evrópusambandið - íslenska - EMA (European Medicines Agency)

opatanol

novartis europharm limited - olópatadínhýdróklóríð - konjunktarbólga, ofnæmi - augnlækningar - meðhöndlun á augnsjúkdómum og einkennum á árstíðabundinni ofnæmishálsbólgu.

Zaditen Augndropar, lausn í stakskammtaíláti 0,25 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

zaditen augndropar, lausn í stakskammtaíláti 0,25 mg/ml

laboratoires thea s.a.s. - ketotifenum fúmarat - augndropar, lausn í stakskammtaíláti - 0,25 mg/ml

Zaditen Augndropar, lausn 0,25 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

zaditen augndropar, lausn 0,25 mg/ml

laboratoires thea s.a.s. - ketotifenum fúmarat - augndropar, lausn - 0,25 mg/ml

Emadine Evrópusambandið - íslenska - EMA (European Medicines Agency)

emadine

immedica pharma ab - emedastine difumarate - konjunktarbólga, ofnæmi - augnlækningar - einkennameðferð við árstíðabundinni ofnæmishálsbólgu.

Lomudal Augndropar, lausn 20 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

lomudal augndropar, lausn 20 mg/ml

stada arzneimittel ag - sodium cromoglicate - augndropar, lausn - 20 mg/ml

Livostin Augndropar, dreifa 0,5 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

livostin augndropar, dreifa 0,5 mg/ml

mcneil sweden ab - levocabastinum hýdróklóríð - augndropar, dreifa - 0,5 mg/ml

Braftovi Evrópusambandið - íslenska - EMA (European Medicines Agency)

braftovi

pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - Æxlishemjandi lyf - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy.

Xylocain Stungulyf, lausn 10 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

xylocain stungulyf, lausn 10 mg/ml

aspen pharma trading limited - lidocainum hýdróklóríð - stungulyf, lausn - 10 mg/ml

Xylocain Stungulyf, lausn 20 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

xylocain stungulyf, lausn 20 mg/ml

aspen pharma trading limited - lidocainum hýdróklóríð - stungulyf, lausn - 20 mg/ml

Xylocain adrenalin Stungulyf, lausn 10 mg/ml+5 míkróg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

xylocain adrenalin stungulyf, lausn 10 mg/ml+5 míkróg/ml

aspen pharma trading limited - lidocainum hýdróklóríð; adrenalinum bítartrat (epinephrinum bítartrat) - stungulyf, lausn - 10 mg/ml+5 míkróg/ml